Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Potkin

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical EEG (Electroencephalography)|July 1, 1996
P50 changes with visual interference in normal subjects: a sensory distraction model for schizophreniaY Jin, S G Potkin
Schizophrenia Bulletin|January 1, 1995
Clozapine increases EEG photic driving in clinical respondersY Jin, S G Potkin, C Sandman
Psychopharmacology Bulletin|January 1, 1980
Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controlsS G Potkin, R J Wyatt, F Karoum
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Neuroleptic plasma concentrations and clinical response: in search of a therapeutic windowJ J Sramek, S G Potkin, R Hahn
Neuropsychologia|February 14, 1998
Lateralized attentional deficits in drug-free and medicated schizophrenic patientsS B Wigal, J M Swanson, S G Potkin
The American Journal of Psychiatry|July 1, 1987
Aids-related complex presenting as psychosisB D Halevie-Goldman, S G Potkin, P Poyourow
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
New morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspectiveB G Bunney, S G Potkin, W E Bunney
Journal of Clinical Psychopharmacology|October 11, 2001
Clozapine enhances neurocognition and clinical symptomatology more than standard neurolepticsS G Potkin, K Fleming, Y Jin, et al.
The American Journal of Psychiatry|April 1, 1979
Platelet monoamine oxidase activity in schizophrenia: a review of the dataR J Wyatt, S G Potkin, D L Murphy
Journal of Psychiatric Research|March 1, 1997
Neuropathological studies of brain tissue in schizophreniaB G Bunney, S G Potkin, W E Bunney
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical EEG (Electroencephalography)|July 1, 1996
P50 changes with visual interference in normal subjects: a sensory distraction model for schizophreniaY Jin, S G Potkin
Schizophrenia Bulletin|January 1, 1995
Clozapine increases EEG photic driving in clinical respondersY Jin, S G Potkin, C Sandman
Psychopharmacology Bulletin|January 1, 1980
Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controlsS G Potkin, R J Wyatt, F Karoum
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Neuroleptic plasma concentrations and clinical response: in search of a therapeutic windowJ J Sramek, S G Potkin, R Hahn
Neuropsychologia|February 14, 1998
Lateralized attentional deficits in drug-free and medicated schizophrenic patientsS B Wigal, J M Swanson, S G Potkin
The American Journal of Psychiatry|July 1, 1987
Aids-related complex presenting as psychosisB D Halevie-Goldman, S G Potkin, P Poyourow
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
New morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspectiveB G Bunney, S G Potkin, W E Bunney
Journal of Clinical Psychopharmacology|October 11, 2001
Clozapine enhances neurocognition and clinical symptomatology more than standard neurolepticsS G Potkin, K Fleming, Y Jin, et al.
The American Journal of Psychiatry|April 1, 1979
Platelet monoamine oxidase activity in schizophrenia: a review of the dataR J Wyatt, S G Potkin, D L Murphy
Journal of Psychiatric Research|March 1, 1997
Neuropathological studies of brain tissue in schizophreniaB G Bunney, S G Potkin, W E Bunney
Pageof 13